Evidence map›Paper›PMID 29750798›Full record

SynthesisPloS one2018

Guidelines for safe handling of hazardous drugs: A systematic review.

Mari A Bernabeu-Martínez, Mateo Ramos Merino, Juan M Santos Gago, Luis M Álvarez Sabucedo, Carmina Wanden-Berghe, Javier Sanz-Valero

Abstract readSystematic Review
In one paragraph

Synthesis in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Review
  8. Article
  9. Longitudinal evaluation of environmental contamination with hazardous drugs by surface wipe sampling.Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners · 2024
    Article
  10. Article
  11. Review
  12. Hazardous medicinal products.European journal of hospital pharmacy : science and practice · 2023
    Article
  13. Article
  14. Validation of chemotherapy drug vapor containment of an air cleaning closed-system drug transfer device.Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners · 2022
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mari A Bernabeu-MartínezDepartment of Public Health and History of Science, School of Medicine, Miguel Hernandez University, Elche, Spain.
Mateo Ramos MerinoDepartment of Telematics Engineering, Telecommunication Engineering School of the University of Vigo, Vigo, Spain.
Juan M Santos GagoDepartment of Telematics Engineering, Telecommunication Engineering School of the University of Vigo, Vigo, Spain.
Luis M Álvarez SabucedoDepartment of Telematics Engineering, Telecommunication Engineering School of the University of Vigo, Vigo, Spain.
Carmina Wanden-BergheHealth and Biomedical Research Institute of Alicante, University General Hospital of Alicante, Alicante, Spain.
Javier Sanz-ValeroDepartment of Public Health and History of Science, School of Medicine, Miguel Hernandez University, Elche, Spain.ORCID 0000-0002-8735-0075

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo review the scientific literature related to the safe handling of hazardous drugs (HDs).

methodCritical analysis of works retrieved from MEDLINE, the Cochrane Library, Scopus, CINHAL, Web of Science and LILACS using the terms "Hazardous Substances", "Antineoplastic Agents" and "Cytostatic Agents", applying "Humans" and "Guidelines" as filters. Date of search: January 2017.

resultsIn total, 1100 references were retrieved, and from those, 61 documents were selected based on the inclusion and exclusion criteria: 24 (39.3%) documents related to recommendations about HDs; 27 (44.3%) about antineoplastic agents, and 10 (33.3%) about other types of substances (monoclonal antibodies, gene medicine and other chemical and biological agents). In 14 (23.3%) guides, all the stages in the manipulation process involving a risk due to exposure were considered. Only one guide addressed all stages of the handling process of HDs (including stages with and without the risk of exposure). The most described stages were drug preparation (41 guides, 67.2%), staff training and/or patient education (38 guides, 62.3%), and administration (37 guides, 60.7%). No standardized informatics system was found that ensured quality management, traceability and minimization of the risks associated with these drugs.

conclusionsMost of the analysed guidelines limit their recommendations to the manipulation of antineoplastics. The most frequently described activities were preparation, training, and administration. It would be convenient to apply ICTs (Information and Communications Technologies) to manage processes involving HDs in a more complete and simpler fashion.

Indexed as

Education, Medical, ContinuingPatient Education as TopicAntineoplastic AgentsHumansMedical StaffPractice Guidelines as TopicAntineoplastic Agents

Identifiers

PMID29750798
PMCPMC5947890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.